Mogrify Limited
2 known investors
Mogrify is a biotechnology company developing in vivo cellular reprogramming therapies, using its proprietary MOGRIFY and epiMOGRIFY platforms that apply transcriptomic and epigenetic data to identify transcription factor combinations for converting one cell type into another. It targets diseases with high unmet clinical need, initially in otology, ophthalmology, and diabetes.
Founders & leadership
JG
Julian GoughCo-founder
OR
Owen RackhamCo-founder
JP
Jose PoloCo-founder
DM
Darrin M. DisleyCEO
JO
Jane OsbournChair
Investors · 2
Companies House · registry record
View on Companies House ↗- Registered name
- MOGRIFY LIMITED
- Company number
- 10002103
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 12 Feb 2016
- Registered office
- 25 Cambridge Science Park, Milton Road, Cambridge, CB4 0FW
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- CELL MOGRIFY LIMITED (2016–2019)
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 21 Mar 2026 · next due 4 Apr 2027
Current officers · 4
- Joe Caddell — director, appointed 19 Feb 2026
- Joe Alan Foster — director, appointed 13 Dec 2022
- Julian Gough — director, appointed 12 Feb 2016
- Joanna Charlotte Antonia Green — director, appointed 21 Jan 2021
Source: Companies House public register · retrieved 8 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.